| Date15.12.2015 |
TitleSwissmedic approves Akynzeo® (netupitant/palonosetron) for use in the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in Switzerland |
Download
Swissmedic approves Akynzeo® (netupitant/palonosetron) for use in the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in Switzerland
|
| Date01.12.2015 |
TitleDivision of the Galenica Group planned for the 4th quarter of 2016 |
Download
Division of the Galenica Group planned for the 4th quarter of 2016
|
| Date22.10.2015 |
TitleSFI acquires Potters and the Equazen™ brand portfolio from Vifor Pharma |
Download
SFI acquires Potters and the Equazen™ brand portfolio from Vifor Pharma
|
| Date30.09.2015 |
TitleKissei receives Japanese approval for P-TOL® (in the USA and Europe commercialized as Velphoro®) |
Download
Kissei receives Japanese approval for P-TOL® (in the USA and Europe commercialized as Velphoro®)
|
| Date31.08.2015 |
TitleMeta-analysis links Ferinject® treatment of iron deficiency to reduced rate for cardiovascular hospitalisations and deaths in systolic heart failure patients |
Download
Meta-analysis links Ferinject® treatment of iron deficiency to reduced rate for cardiovascular hospitalisations and deaths in systolic heart failure patients
|
| Date11.08.2015 |
TitleGalenica Group half-year results 2015 |
Download
Galenica Group half-year results 2015
|
| Date11.08.2015 |
TitleVifor Fresenius Medical Care Renal Pharma and Relypsa Enter into Partnership to Commercialize Patiromer Fos in Europe and Additional Territories |
Download
Vifor Fresenius Medical Care Renal Pharma and Relypsa Enter into Partnership to Commercialize Patiromer Fos in Europe and Additional Territories
|
| Date11.08.2015 |
TitleVifor Fresenius Medical Care Renal Pharma enters into partnership with Relypsa to commercialise Patiromer FOS |
Download
Vifor Fresenius Medical Care Renal Pharma enters into partnership with Relypsa to commercialise Patiromer FOS
|
| Date03.07.2015 |
TitleGalenica Santé: new strategic priorities and changes to the organisational structure |
Download
Galenica Santé: new strategic priorities and changes to the organisational structure
|
| Date28.05.2015 |
TitleGalenica and Roche enter into exclusive license agreement for the commercialisation of Mircera® in the US |
Download
Galenica and Roche enter into exclusive license agreement for the commercialisation of Mircera® in the US
|
| Date28.05.2015 |
TitleVifor Fresenius Medical Care Renal Pharma to expand its business activities |
Download
Vifor Fresenius Medical Care Renal Pharma to expand its business activities
|
| Date07.05.2015 |
Title2015 Annual General Meeting of Galenica Ltd. |
Download
2015 Annual General Meeting of Galenica Ltd.
|
| Date13.04.2015 |
TitleMeasures to ensure strategy implementation |
Download
Measures to ensure strategy implementation
|
| Date10.03.2015 |
TitleResults of the Galenica Group for 2014 |
Download
Results of the Galenica Group for 2014
|
| Date27.01.2015 |
TitleVelphoro® receives Swissmedic approval |
Download
Velphoro® receives Swissmedic approval
|
| Date21.01.2015 |
TitleGalenica Group sales 2014 |
Download
Galenica Group sales 2014
|